About Radiopharmaceutical Therapy
Radiopharmaceutical therapy (also called targeted radionuclide therapy or molecular radiotherapy) involves a radioactive drug compound that seeks and destroys cancer cells.
Most radiopharmaceuticals consist of a small amount of radioactive material — called a radionuclide — combined with a cell-targeting molecule. When injected into the patient’s bloodstream, the radiopharmaceutical travels to and delivers radiation directly to disease sites. Because it is highly selective in its ability to damage cancerous cells while limiting radiation exposure to healthy tissue, molecular therapy is known as a targeted therapy.